779323-58-9 Usage
Uses
Used in Pharmaceutical Industry:
2,4-Dichloro-6,7-dihydro-6-(benzyl)-5H-pyrrolo[3,4-d]pyrimidine is used as a potential candidate for drug development due to its unique structure and biological activities. Its specific applications in this industry are subject to ongoing research and discovery, as its precise uses are still being explored.
Used in Agrochemical Industry:
Similarly, in the agrochemical industry, 2,4-Dichloro-6,7-dihydro-6-(benzyl)-5H-pyrrolo[3,4-d]pyrimidine is considered a potential candidate for the development of new crop protection agents. Its role in this field is also under investigation, with ongoing research aimed at uncovering its full potential and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 779323-58-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,9,3,2 and 3 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 779323-58:
(8*7)+(7*7)+(6*9)+(5*3)+(4*2)+(3*3)+(2*5)+(1*8)=209
209 % 10 = 9
So 779323-58-9 is a valid CAS Registry Number.
779323-58-9Relevant academic research and scientific papers
KRAS G12C Mutant protein inhibitors
-
, (2021/11/26)
The invention discloses compounds which irreversibly inhibit KRAS G12C mutation. A pharmaceutically acceptable salt and of the compound contains the compound or a salt thereof, and the invention also discloses an application of the compound or a salt and of the compound in the treatment KRAS G12C of a proliferative disease such as a sudden tumor.
Pyrrolidine [3,4-d] pyrimidine derivatives, preparation method and its application
-
, (2016/12/01)
The invention discloses a pyrrolidine[3,4-d]pyrimidine derivative and a preparation method and an application thereof. The pyrrolidine[3,4-d]pyrimidine derivative is an inhibitor of a type I insulin-like growth factor receptor (IGF-1R), and has a good IGF-1R inhibiting function and a good cancer cell proliferation inhibiting function, so that the pyrrolidine[3,4-d]pyrimidine derivative can be taken as a therapeutic agent for treating tumors and relevant diseases.
